ULTRA-DD Annual Conference and SGC Immunology Day


Cell and Molecular Biology Lecture Hall (CMB)

Berzelius väg 21 – Karolinska Institutet Solna Campus

[click for map on Google]


8:30 Arrival, coffee and get-together
8:45 Welcome and introduction about ULTRA-DD
Michael Sundstrom (Karolinska)
9:00 The importance of jointly funded translational medicine IMI projects
9:15 Target selection and prioritization
Julian Knight et al. (Oxford)
9:45 Converting prioritized targets into protein samples and antibody research tools
Nicola Burgess-Brown (Oxford) and Susanne Gräslund (Karolinska) et al.
10:15 Predictive cell-based assays as a foundation for research tool identification and generation
Gillian Farnie, Kilian Huber, Oleg Fedorov (Oxford) et al.
10:45 Coffee Break
11:00 Shedding light on protein structure and function
Katharina Duerr, Liz Carpenter, Frank von Delft (Oxford) and Matthias Gstaiger (ETH Zurich) et al.
11:30 Generating high quality chemical probes for target validation
Paul Brennan (Oxford) et al.
12:00 Better translational assays based on patient material
Louise Berg (Karolinska), Fiona McCann (Oxford) et al.
12:00 Maximinsing impact: communication of results and creating research networks
Brian Marsden, Wen Hwa Lee (Oxford) et al.
13:00 Lunch and Networking
  Showcase on Collaborative Initiatives with ULTRA-DD
14:00 Boehringer-Ingelheim’s approach to Open Science
Adrian Carter (Corporate VP and Global Head Discovery Research Coordination)
14:20 Research and clinical aspects of IBD

Ola Winqvist (Professor of cellular immunotherapy, KI)

14:40 Drug Development and Discovery Platform at Science for Life Laboratory at Karolinska Institutet
Per Arvidsson (Exec. Director Drug Discovery & Development, Science for Life)
15:00 The IMI European Lead Factory (ELF)
Jon de Vlieger (Business developer Lygature/ ELF)
15:20 Coffee Break
15:30 The merits of Open Science – Panel Discussion
16:00 Wrap-up and end of meeting
glqxz9283 sfy39587stf02 mnesdcuix8